Classification (Agonist/Antagonist) and Regression “Structure-Activity” Models of Drug Interaction with 5-HT6

E-ISSN： 1875-6166|18|3|213-221

ISSN： 1871-5249

Source： Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol.18, Iss.3, 2018-12, pp. : 213-221

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Analysis of competitive agonist-antagonist interactions by nonlinear regression

By Lew M.J. Angus J.A.

Trends in Pharmacological Sciences, Vol. 16, Iss. 10, 1995-10 ,pp. : 328-337

Elsevier

Access to resources Recommend Favorite

Antagonist activity of meta-chlorophenylpiperazine and partial agonist activity of 8-OH-DPAT at the 5-HT 7 receptor

By Wood M. Chaubey M. Atkinson P. Thomas D.R.

European Journal of Pharmacology, Vol. 396, Iss. 1, 2000-05 ,pp. : 1-8

Elsevier

Access to resources Recommend Favorite

Synthesis, Testing and Structure-Activity Studies on a Library of 5-HT4 Ligands

Medicinal Chemistry, Vol. 6, Iss. 6, 2010-11 ,pp. : 344-354

Bentham Science Publishers

Access to resources Recommend Favorite

Quantitative structure-activity relationships in the 8-amino-6,7,8,9-tetrahydro-3H-benz[e]indole ring system. Analysis of serotonin 5-HT 1A effects in vivo and in vitro via partial least squares regression

By Hansson L. Ennis M. Stjernlof P.

European Journal of Medicinal Chemistry, Vol. 32, Iss. 7, 1997-07 ,pp. : 571-582

Elsevier

Access to resources Recommend Favorite

D 1 Agonist and/or D 2 antagonist dopamine receptor properties of a series of ergoline derivatives: a structure-activity study

By Mantegani S. Arlandini E. Bandiera T. Borghi D. Brambilla E. Caccia C. Cervini M.A. Cremonesi P. McArthur R.A. Traquandi G. Varasi M.

European Journal of Medicinal Chemistry, Vol. 34, Iss. 2, 1999-02 ,pp. : 107-124

Elsevier

Access to resources Recommend Favorite